We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection

By LabMedica International staff writers
Posted on 02 Mar 2026

Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. More...

The condition occurs when bacteria or fungi infect tissues around an implanted artificial joint and, in severe cases, can lead to amputation or death. Diagnosing PJI is challenging due to variable symptoms, co-morbidities, and the absence of a gold standard test in the U.S. Now, a new machine learning-based diagnostic tool has demonstrated significantly improved accuracy and confidence in diagnosing PJI compared to traditional approaches.

The study evaluated the SynTuition algorithm, developed by Zimmer Biomet (Warsaw, IN, USA), that analyzes results from the company’s Synovasure comprehensive PJI test panel, which measures 11 synovial fluid biomarkers. Unlike traditional tests that rely heavily on culture results, SynTuition identifies patterns in biomarker data to generate a continuous probability score from 0 to 100, estimating a patient’s likelihood of infection. Scores of 80 or higher indicate high probability, below 20 indicate low probability, and values between 20 and 80 are considered intermediate. The tool quantifies uncertainty, helping clinicians make more informed treatment decisions.

The study, published in Diagnostics, compared SynTuition’s performance with diagnoses made by 12 physicians across 274 real-world cases. The algorithm matched expert diagnoses 96% of the time, outperforming the pooled physician group, which matched experts 91% of the time. In inconclusive cases, physicians showed indecision rates ranging from 38% to 48%, while SynTuition produced definitive diagnoses with 87% agreement against experts. The algorithm reduced uncertain results to just 0.4%. It was trained on one of the largest synovial biomarker datasets and validated on an independent cohort of 20,818 samples, demonstrating strong diagnostic accuracy without relying on culture data.

By generating patient-specific probability scores rather than binary results, the tool may reduce unnecessary revision surgeries and prolonged antibiotic treatments. More accurate early diagnosis could also help prevent failed revision procedures, repeated surgeries, and extended hospital stays. As machine learning continues to integrate into orthopedic care, tools like SynTuition may strengthen clinical decision-making, particularly in complex or borderline cases where traditional tests provide conflicting information.

“This study shows that SynTuition can meaningfully support clinicians, especially when cases fall into a gray area where traditional tests offer conflicting or unclear results,” said orthopedic surgeon Dr. James Baker, a study co-author. “We feel it is a valuable addition to the clinical pathway to improve patient safety, with the added benefit of reducing the cost of potentially unnecessary care.”

Related Links:
Zimmer Biomet


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
All-in-One Molecular System
AIO M160
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.